Immune-mediated Colitis (IMC)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Immune-mediated Colitis (IMC) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT06499896

Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Im…

Multiple retrospective studies suggest that the administration of corticosteroids to treat irAEs is safe, and does not compromise efficacy of ICI therapy in can…

United States30 participantsStarted 2025-01-23

Treatment: MTP-101-C

Immune-mediated Colitis (IMC)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Im…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Im…

All recent trials (1 shown)